French Observatory of Rare Malignant Tumors of the Ovary

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
ARCAGY/ GINECO GROUP
ClinicalTrials.gov Identifier:
NCT01304043
First received: September 9, 2005
Last updated: April 19, 2012
Last verified: April 2012

September 9, 2005
April 19, 2012
January 2002
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT01304043 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
French Observatory of Rare Malignant Tumors of the Ovary
Observatoire Francophone Des Tumeurs Malignes Rares de l'Ovaire : Protocole de Prise en Charge Chez l'Adulte (Tumeurs Germinales et Des Cordons Sexuels)

To take charge of the treatment in rare adult ovarian tumors with an homogenous manner (germinal and sexual cords tumors), at different stages of the disease.

  • to establish prognosis factors for the disease
  • to proceed in a centralised examination of histologic laminas
  • to reach in the long-term and homogenous follow-up of the patients
  • to follow-up the long-term toxicities of the treatments given
  • to analyse and follow-up the later fertility of the patients
  • to evaluate the interest of setting a multi-disciplinary discussion forum on the Web
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

female with rare ovarian cancer

Ovarian Tumors
Drug: chemotherapies protocols
Cisplatine 20 mg/m² IV Etoposide 100 mg/m² IV Bléomycine 30 mg IV
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
204
June 2011
Not Provided

Inclusion Criteria:

  • age > 18 years old
  • germinal or sexual cords ovary tumors histologically proven
  • first line or relapse treatment
  • written informed consent

Exclusion Criteria:

  • mental ineptitude to understand and follow the study
Female
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT01304043
TMRO
No
ARCAGY/ GINECO GROUP
ARCAGY/ GINECO GROUP
Not Provided
Principal Investigator: Isabelle Ray-Coquard, Physician GINECO
ARCAGY/ GINECO GROUP
April 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP